ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
2026-02-04 13:32:33 ET
More on related tickers
- Trane Technologies: Upgrade To Buy On Cheaper Valuation And Better Fundamentals
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Linde Q4 2025 Earnings Preview
- Genentech in up to $1.7B RNAi licensing deal with SanegeneBio
Read the full article on Seeking Alpha
For further details see:
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025NASDAQ: TT
TT Trading
-0.48% G/L:
$419.015 Last:
544,111 Volume:
$427.24 Open:



